Trump Media & Technology (DJTWW) had the highest return in Q1 2024 by a mid-cap US stock, returning 446.9%.

ASSET	QUARTER	% RETURN
Trump Media & Technology (DJTWW)	Q1 2024	446.91%
Dave (DAVE)	Q1 2024	355.71%
Viking Therapeutics (VKTX)	Q1 2024	342.53%
Sezzle (SEZL)	Q1 2024	302.33%
Trump Media & Technology (DJT)	Q1 2024	251.25%
GeneDx (WGS)	Q1 2024	238.15%
WM Technology (MAPSW)	Q1 2024	225%
Arcutis Biotherapeutics (ARQT)	Q1 2024	212.62%
SoundHound AI (SOUN)	Q1 2024	176.53%
Praxis Precision Medicines (PRAX)	Q1 2024	174.37%
Apogee Therapeutics, Inc Common Stock (APGE)	Q1 2024	142.08%
Mesoblast (MESO)	Q1 2024	131.94%
Dyne Therapeutics (DYN)	Q1 2024	118.05%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	Q1 2024	111.16%
Ocular Therapeutix (OCUL)	Q1 2024	106.82%
Tarsus Pharmaceuticals (TARS)	Q1 2024	81.75%
Rumble (RUM)	Q1 2024	79.56%
Banco Macro SA B ADR (BMA)	Q1 2024	74.75%
CleanSpark (CLSK)	Q1 2024	68.33%
Merus (MRUS)	Q1 2024	66.1%
CAVA (CAVA)	Q1 2024	65.1%
Oscar Health (OSCR)	Q1 2024	64.67%
Nuscale Power (SMR)	Q1 2024	63.89%
Powell Industries (POWL)	Q1 2024	63.73%
PureCycle Technologies (PCTTW)	Q1 2024	62.28%

Mid-cap stocks are treated as having a market cap between $2B and $10B.